Join to view full profile
20 York St Np4New Haven, CT 06510
Phone+1 203-200-5864
Fax+1 203-688-3501
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frederick Wilson, MD is an oncologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Massachusetts.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007
Certifications & Licensure
CT State Medical License 2017 - 2026
MA State Medical License 2009 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- 35 citationsMAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.Mrinal Gounder, Melissa Johnson, Rebecca S Heist, Geoffrey I Shapiro, Sophie Postel-Vinay
Nature Communications. 2025-01-06 - 3 citationsA destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition.Daniel S Lenchner, Zaritza O Petrova, Lisa Hunihan, Kumar D Ashtekar, Zenta Walther
NPJ Precision Oncology. 2024-01-05 - 12 citationsRASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.Lisa Hunihan, Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian
Clinical Cancer Research. 2022-07-15
Grant Support
- Regulatory Pathways Compromised by PRMT5 Inhibition in Cancers with MTAP LossYALE UNIVERSITY2025–2029
